When MarketSmith / MarketSurge Doesn't Fit
MarketSmith (now branded as MarketSurge in IBD's current product family) is Investor's Business Daily's growth-stock research platform built around CAN SLIM ratings, chart pattern recognition, and IBD's proprietary Composite Rating. It's the reference tool for growth investors who follow William O'Neil's methodology. Three limits push traders elsewhere: expensive at $149.95/mo, CAN SLIM-specific methodology that doesn't fit value or momentum styles, and US stocks only.
The alternative depends on your style. If you want free CAN SLIM-adjacent screening: Finviz's technical + fundamental filters can approximate the setup. If you want modern chart analysis + AI: TrendSpider. If you want fundamental screener: Stock Rover. If you want comprehensive research terminal: Koyfin Pro.
Best MarketSmith / MarketSurge Alternatives by Use Case
| Use Case | Best Alternative | Why It Fits |
|---|---|---|
| Free stock screener with technicals | Finviz | 60+ filters covering fundamentals + technicals + patterns. Free covers most CAN SLIM screening needs. |
| Plain-English screening + charts | TC2000 | EasyScan + charting + broker execution. Not CAN SLIM-native but flexible. |
| AI-assisted chart pattern recognition | TrendSpider | Automated pattern detection + AI analysis. Modern take on the chart-first approach. |
| Deep fundamental screener | Stock Rover | Best fundamental screener + portfolio analysis. Different methodology but similar depth. |
| Comprehensive research terminal | Koyfin Pro | Web terminal with fundamentals, screener, macro. Broader than growth-stock focus. |
| Community-driven research | Seeking Alpha | Analyst deep-dives + growth stock coverage. Different format but similar audience. |
What MarketSmith / MarketSurge Does Better
Two things: proprietary IBD ratings (Composite, EPS, RS, SMR) and CAN SLIM-native workflows. No competitor calculates the exact same rating structure, and no competitor is as focused on growth-investor methodology. If you follow CAN SLIM strictly, you're paying for a purpose-built tool.
Weekly Big Picture columns, MarketSurge's improved chart pattern detection, and the IBD 50 / IBD Big Cap 20 lists are proprietary content you can't get elsewhere. For growth-style traders who value the IBD ecosystem, staying makes sense.
Cost Comparison
- MarketSmith / MarketSurge: $149.95/mo. Growth-stock research + CAN SLIM ratings.
- Finviz: Free + Elite $39.50/mo.
- TC2000: Gold $12.98/mo, Platinum $34.98/mo.
- TrendSpider: Essential $27/mo, Advanced $58/mo, Elite $97/mo.
- Stock Rover: Free + Premium tiers up to ~$28/mo.
- Koyfin Pro: ~$40/mo. Web terminal.
- Seeking Alpha Premium: $239/year (~$20/mo).
The Bottom Line
MarketSmith / MarketSurge is the CAN SLIM growth-investor platform. If you follow IBD's methodology closely, the proprietary ratings + IBD content aren't fully replaceable elsewhere. If you want a cheaper toolkit that approximates the setup, combine Finviz (screening) + TrendSpider (chart patterns) + Stock Rover (fundamentals) — total cost still under MarketSmith. See the best stock screeners list for the full comparison.